Andere talen Hyundai Pharmaceutical Co., Ltd.

Aandelen

A004310

KR7004310009

slotkoers Korea S.E. Andere beurzen 00:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3.800 ^KRW	-0,26%		+1,33%	-7,54%

2023	Hyundai Pharmaceutical Co, Ltd. (KOSE:A004310) kondigt een aandeleninkoop aan voor KRW 3.000 miljoen aan aandelen.	CI
2023	Hyundai Pharmaceutical Co., Ltd. keurt een terugkoopplan goed.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	16-10-23
Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index	18-09-23
Hyundai Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	14-07-23
Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	14-07-23
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22-06-23
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22-06-23
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22-06-23
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22-06-23
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22-06-23
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 23, 2022, has expired with 968,118 shares, representing 3.50% for KRW 4,388.11 million.	22-06-23
Hyundai Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.	23-06-22
Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	23-06-22
Market Chatter: Hyundai Pharmaceutical Seeks Regulatory Approval to Market Abortion Pill in South Korea	07-07-21
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 14, 2008, has expired.	08-04-21
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on April 22, 2010, has expired.	08-04-21
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 28, 2019, has expired.	08-04-21
Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) added to S&P Global BMI Index	21-09-20
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till June 25, 2021.	26-06-20
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till April 16, 2021.	14-04-20
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 28, 2019.	27-09-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hyundai Pharmaceutical Co., Ltd.

Aandelen

A004310

KR7004310009

Andere talen

Filters